首页|期刊导航|保健医学研究与实践|慢性心功能不全急性加重期患者AST/ALT、NLR、PLR水平及临床意义

慢性心功能不全急性加重期患者AST/ALT、NLR、PLR水平及临床意义OA

Levels and clinical significance of AST/ALT,NLR,and PLR in patients with acute decompensated chronic heart failure

中文摘要英文摘要

目的 探讨谷草转氨酶/谷丙转氨酶比值(AST/ALT)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)在慢性心功能不全急性加重期(ADHF)患者中的变化及临床价值.方法 回顾性选取成都市第三人民医院 2022 年1 月—2024 年 12 月收治的 118 例 ADHF 患者纳入 ADHF 组,100 例慢性心功能不全(CHF)稳定期患者纳入对照组,比较2 组患者的 AST/ALT、NLR、PLR 水平,并采用 Spearman 相关分析探讨各指标与心肌损伤标志物[N 末端 B 型钠尿肽前体(NT-proBNP)和乳酸脱氢酶(LDH)]的相关性;随访 6 个月,根据预后将 ADHF 患者分为预后不良组(n=50)和预后良好组(n=68),比较不同预后患者的 AST/ALT、NLR、PLR 水平,并采用受试者工作特征(ROC)曲线和曲线下面积(AUC)分析各指标对 ADHF 患者预后的预测价值.结果 ADHF 组患者 AST/ALT、NLR、PLR、NT-proBNP 及 LDH 水平均高于对照组,差异均有统计学意义(Z/t=12.003、19.282、32.917、29.679、12.714,均 P<0.001).Spearman 相关分析结果显示,ADHF 患者血清 AST/ALT、NLR、PLR 水平与 NT-proBNP 及 LDH 水平均呈正相关(P<0.05).预后不良组患者AST/ALT、NLR、PLR 水平均高于预后良好组,差异均有统计学意义(P<0.05).ROC 曲线分析结果显示,AST/ALT、NLR、PLR 预测 ADHF 患者不良预后的 AUC 分别为 0.823(95%CI:0.747~0.899)、0.820(95%CI:0.744~0.896)、0.810(95%CI:0.732~0.887);三者联合预测 ADHF 患者不良预后的 AUC 为 0.958(95%CI:0.926~0.989),高于各指标单独预测的效能(Z=3.726、3.829、4.025,P<0.001).结论 ADHF 患者 AST/ALT、NLR、PLR 水平均异常升高,对患者预后均具有较高的预测效能,且联合检测的预测效能更高.临床可动态监测三者水平变化,尽早识别高危人群并开展针对性干预,从而改善患者结局.

Objective To investigate the changes and clinical value of aspartate aminotransferase-to-alanine aminotransferase ratio(AST/ALT),neutrophil-to-lymphocyte ratio(NLR),and platelet-to-lymphocyte ratio(PLR)in patients with acute decompensated heart failure(ADHF).Methods A total of 118 patients with ADHF admitted to The Third People's Hos-pital of Chengdu from January 2022 to December 2024 were retrospectively selected as the ADHF group,and 100 patients with stable chronic heart failure(CHF)were selected as the control group.The levels of AST/ALT,NLR,and PLR were compared between the two groups,and Spearman correlation analysis was used to explore the correlations of these indicators with myocardial injury markers(N-terminal pro-brain natriuretic peptide[NT-proBNP]and lactate dehydrogenase[LDH]).After 6 months of follow-up,patients with ADHF were assigned to a poor prognosis group(n=50)and a good prognosis group(n=68)according to prognosis.The levels of AST/ALT,NLR,and PLR were compared between patients with different prognoses.Receiver operating characteristic(ROC)curves and area under the curve(AUC)were adopted to analyze the predictive value of each indicator for the prognosis of ADHF patients.Results The levels of AST/ALT,NLR,PLR,NT-proBNP,and LDH in the ADHF group were significantly higher than those in the control group(Z/t=12.003,19.282,32.917,29.679,12.714;P<0.001).Spearman correlation analysis showed that serum AST/ALT,NLR,and PLR levels in ADHF patients were positively correlated with NT-proBNP and LDH levels(P<0.05).The levels of AST/ALT,NLR,and PLR in the poor prognosis group were significantly higher than those in the good prognosis group(P<0.05).ROC curve analysis showed that the AUCs of AST/ALT,NLR,and PLR for predicting poor prognosis in ADHF patients were 0.823(95%CI:0.747-0.899),0.820(95%CI:0.744-0.896),and 0.810(95%CI:0.732-0.887),re-spectively.The AUC of the combination of the three indicators for predicting poor prognosis in ADHF patients was 0.958(95%CI:0.926-0.989),which was higher than that of each indicator alone(Z=3.726,3.829,4.025;P<0.001).Con-clusion The levels of AST/ALT,NLR,and PLR are abnormally elevated in patients with ADHF,and all have high predic-tive performance for patient prognosis,with the combined detection indicating even higher predictive performance.Clinical-ly,dynamic monitoring of the changes in these three indicators can help identify highrisk populations early and conduct tar-geted interventions,thereby improving patient outcomes.

张人予;郑永玲;李璐娜;钟倩;王月书;周琴;刘晶晶

西南交通大学附属医院/成都市第三人民医院心内科,成都 610031西南交通大学附属医院/成都市第三人民医院心内科,成都 610031西南交通大学附属医院/成都市第三人民医院心内科,成都 610031西南交通大学附属医院/成都市第三人民医院心内科,成都 610031西南交通大学附属医院/成都市第三人民医院心内科,成都 610031西南交通大学附属医院/成都市第三人民医院心内科,成都 610031西南交通大学附属医院/成都市第三人民医院心内科,成都 610031

医药卫生

慢性心功能不全急性加重期谷草转氨酶/谷丙转氨酶比值中性粒细胞与淋巴细胞比值血小板与淋巴细胞比值预测价值

Chronic heart failureAcute exacerbationAST/ALT ratioNeutrophil-to-lymphocyte ratioPlatelet-to-lympho-cyte ratioPredictive value

《保健医学研究与实践》 2026 (7)

37-43,59,8

四川省科技计划项目(2023YFS0298).

10.11986/j.issn.1673-873X.2026.07.06

评论